SAB Biotherapeutics, Inc. (NASDAQ:SABSW – Get Free Report) was the recipient of a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 900 shares, a decline of 25.0% from the February 13th total of 1,200 shares. Based on an average daily trading volume, of 32,000 shares, the short-interest ratio is presently 0.0 days.
SAB Biotherapeutics Stock Down 12.5 %
Shares of SABSW opened at $0.03 on Friday. The stock has a 50 day moving average of $0.06 and a 200 day moving average of $0.05. SAB Biotherapeutics has a 12 month low of $0.01 and a 12 month high of $0.18.
SAB Biotherapeutics Company Profile
Read More
- Five stocks we like better than SAB Biotherapeutics
- How to Profit From Value Investing
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- How to trade using analyst ratings
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Technology Stocks Explained: Here’s What to Know About Tech
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for SAB Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SAB Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.